Clinical determinants of relapse following CAR-T therapy for hematologic malignancies: Coupling active strategies to overcome therapeutic limitations
Le Wang
Topics & Concepts
Chimeric antigen receptorMedicineClinical trialCAR T-cell therapyDiseaseLymphomaImmunogenicityCancerOncologyImmunologyIntensive care medicineAntigenImmunotherapyInternal medicineCAR-T cell therapy researchViral Infectious Diseases and Gene Expression in InsectsCRISPR and Genetic Engineering